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Abstract  The  term  orbital  tumor  covers  a  wide  range  of  benign  and  malignant  diseases
affecting speciﬁc  component  of  the  orbit  or  developing  in  contact  with  them.  They  are  found
incidentally  or  may  be  investigated  as  part  of  the  assessment  of  a  systemic  disorder  or  because
of orbital  signs  (exophthalmos,  pain,  etc.).  Computed  tomography,  MRI  and  Color  Doppler  Ultra-
sound (CDU),  play  a  varying  role  depending  on  the  clinical  presentation  and  the  disease  being
investigated.  This  article  reﬂects  long  experience  in  a  reference  center  but  does  not  claim  to
be exhaustive.  We  have  chosen  to  consider  these  tumors  from  the  perspective  of  their  usual
presentation,  emphasizing  the  most  common  causes  and  suggestive  radiological  and  clinical
presentations  (progressive  or  sudden-onset  exophthalmos,  children  or  adults,  lacrimal  gland
lesions, periorbital  lesions  and  enophthalmos).  We  will  describe  in  particular  muscle  involve-
ment (thyrotoxicosis  and  tumors),  vascular  lesions  (cavernous  sinus  hemangioma,  orbital  varix,
cystic lymphangioma),  childhood  lesions  and  orbital  hematomas.  We  offer  straightforward  use-
ful protocols  for  simple  investigation  and  differential  diagnosis.  Readers  who  wish  to  go  further
to extend  their  knowledge  in  this  fascinating  area  can  refer  to  the  references  in  the  bibliography.
© 2014  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Orbital  tumors  may  be  discovered  on  imaging  in  many  circumstances  [1].  They  may
be  found  incidentally  on  a CT  or  MRI  of  the  brain  or  facial  bones,  performed  for  a  non-
ophthalmological  disease.  Alternatively,  the  lesion  may  be  looked  for  directly  in  a  patient
with  ophthalmological  signs  such  as  exophthalmos,  unilaterally  reduced  visual  acuity,
diplopia,  and  orbital  or  periorbital  pain.
These  imaging  modalities  play  a  major  role  in  the  diagnostic  and  staging  assessment  of
the  lesion,  guide  therapeutic  decision  and  can  be  used  for  simple  monitoring  or  follow  up
on  treatment.
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maging: what to use and what protocol?
adiologists  have  three  methods  of  examining  the  orbit  [2].
hese  can  be  used  either  in  isolation  or  in  combination,
epending  on  the  clinical  and  anatomical  features.  Imaging
s  used  to  conﬁrm  exophthalmos  and  deﬁne  its  grade  from
he  external  bicanthal/eye  globe  line  ratio.  A  line  crossing
he  posterior  third  deﬁnes  the  grade  I,  one  next  to  the  pos-
erior  pole  deﬁnes  the  grade  II,  and  one  passing  behind  the
osterior  pole  deﬁnes  the  grade  III.  The  grade  is  one  of  the
actors  used  in  monitoring  the  disease,  as  the  risk  of  the
esion  damaging  the  optic  nerve  as  a  result  of  stretching
ncreases  with  grade.
Color  Doppler  Ultrasound  (CDU)  is  extremely  useful  if  a
ascular  lesion  is  expected  (blue-colored  mass,  varying  with
ead  position,  concomitant  conjunctival  abnormalities),  for
n  anterior  lesion  (lacrimal  gland  or  eyelid),  and  when  evi-
ence  is  needed  to  distinguish  between  inﬂammation  and
ymphoma.  A  high  frequency  probe  is  used,  applied  directly
o  the  lesion  or  examining  the  lesion  through  gel  applied
o  the  closed  eyelid.  The  Valsalva  maneuver  and  patient
yperextension  method  improve  the  diagnosis  of  an  orbital
arix.
Computed  tomography  is  used  to  examine  the  orbital
all,  to  demonstrate  calciﬁcations  inside  lesions  and  to
escribe  their  morphology  (small  bead  appearance  of  phle-
oliths,  or  lumps  shaped  calciﬁcations  in  cartilaginous
esions).  It  can  be  useful  for  positional  maneuvers  (imag-
ng  in  prone  position  is  used  to  assess  an  orbital  varix).  The
nvestigation  is  started  with  an  unenhanced  study  unless
rbital  cellulitis  is  suspected,  when  contrast  injection  at  the
utset  is  sufﬁcient  to  conﬁrm  the  diagnosis  and  for  the  stag-
ng  assessment.  Either  conventional  enhancement  or  arterial
r  venous  CT  angiography  may  be  used  depending  on  the
uspected  disease.  When  an  orbital  varix  is  investigated,
onventional  images  with  the  patient  in  supine  position  are
upplemented  with  a  second  CT  acquisition  with  the  patient
n  prone  position  in  order  to  demonstrate  the  increase  in  the
olume  of  the  lesion  which  is  typical  of  this  pathology.
MRI  remains  the  reference  method  to  type  the  lesion,
ssess  extension  and  investigate  for  any  concomitant  cere-
ral  abnormalities.  In  addition  to  patients  with  pacemakers,
t  is  contraindicated  in  patients  with  intra  or  periorbital
etal  foreign  bodies.  It  can  be  performed  in  patients  who
ave  had  local  radiotherapy  for  a  choroid  melanoma  and
atients  can  continue  to  wear  their  contact  lenses.  Makeup
owever  may  cause  very  troublesome  artifacts.  We  recom-
end  that  centers  that  carry  out  orbital  MRI  have  their
ecretaries  inform  patients  to  avoid  wearing  any  makeup
nd  to  have  access  to  makeup  remover  and  cotton  wool  pads
or  patients  who  did  not  follow  their  advice!  MRI  provides
nformation  about  the  site,  morphology  and  structure  of  the
esion.
We  propose  the  following  protocol.  The  patient  is  asked
o  relax  and  to  keep  his  eyes  shut.
After  a  scout  view  focused  on  the  orbit,  we  perform
hin  (3  mm)  axial  T1  and  diffusion  sequence  following  the
nteroposterior  axis  of  the  orbit  (grading  the  exophthalmos,
nalyzing  the  orbital  apex),  thin  (2  mm)  coronal  T2  sequence
erpendicular  to  the  former  one,  from  the  anterior  part  of
he  ocular  bulb  to  orbital  apex.  Injection  is  either  classical  or
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icrovascularization)  and  followed  by  thin  axial  and  coro-
al  and/or  sagittal  T1  FATSAT  sequences.  Depending  on  the
esults  of  this  ﬁrst  step,  complementary  sequences  may  be
roposed  such  as  prone  position  axial  T1  GD  FATSAT  acquisi-
ion  (to  depict  an  orbital  varix),  axial  and  coronal  T2  FATSAT
tudy  of  the  face  and  upper  cervical  area  (extension  of  an
emangiolymphoma),  brain  study.  If  a  vascular  malformation
r  an  aneurysm  is  suspected,  MRA  (either  TOF  or  dynamic
ngiography)  is  added.
A few  important  points  must  be  remembered.  Fat  sup-
ression  (FATSAT)  after  injection  is  used  routinely,  as  it
mproves  the  detection  of  contrast  enhancement  and  offers
 clear  detection  of  the  boundaries  of  the  lesion  and  its
elationships  with  orbital  structures  (optic  nerve,  apex  mus-
les).  This  is  required  particularly  to  assess  posterior  lesions,
s  identiﬁcation  of  extension  towards  the  superior  orbital
ssure  is  seen  far  more  clearly  than  without  fat  suppression.
he  contrast  injection  may  be  given  during  a  T1  weighted
erfusion  sequence  (or  dynamic  injection)  which  assesses
he  tumor  microvascularization.  This  perfusion  weighted
mage  has  been  used  for  several  years  to  characterize  par-
icularly  salivary  ENT  lesions,  and  also  for  breast  and  liver
umors.  Its  use  in  ophthalmology  is  more  recent  [3].  Results
orrelate  well  with  those  found  for  other  sites  of  lesion.  The
esults  of  the  T1  perfusion  weighted  image  are  described  in
 2011  article  [4]  in  16  cases  of  malignant  orbital  tumors
nd  43  cases  of  benign  orbital  tumors.  The  authors  showed
hat  all  of  the  tumors  which  had  a  persistent  pattern  or  type
 curve  were  benign,  those  with  a  steep  slope  and  plateau
attern  or  type  II  were  either  benign  or  malignant,  and  those
ith  a  rapid  rise  and  peak  (washout  pattern)  or  type  III  were
ore  likely  to  be  malignant.  The  use  of  various  criteria  from
hese  dynamic  studies  should  help  to  improve  distinctions
etween  benign  and  malignant  and  improve  characteriza-
ion  of  masses  within  each  category.
rogressive exophthalmos
rogressive  exophthalmos  suggests  an  intra-orbital  space
ccupying  lesion.  This  lesion  may  be  born  from  anatomical
rbital  component  (muscle,  vessels,  lacrimal  gland,  optic
erve,  orbital  wall)  or  non-orbital  components  (tumor  or
nfection).
xophthalmos of  muscular origin
his  is  a  common  cause  of  exophthalmos,  and  when  bilat-
ral,  even  asymmetrical  the  ﬁrst  consideration  should
e  a  metabolic  cause  and,  because  of  its  frequency,
ysimmune  orbital  disease  usually  related  to  autoimmune
yperthyroidism  (Basedow’s  disease).  This  disease  affects
he  oculomotor  muscles  (the  superior,  medial  and  inferior
ectus  muscles,  the  superior  oblique  and  far  more  rarely
he  lateral  rectus)  and  the  orbital  fat.  The  exophthalmos
s  due  to  hypertrophy  of  these  muscles,  the  bodies  of  which
ontain  deposits  of  mucopolysaccharides,  fat  and  inﬂamma-
ory  cells.  These  modiﬁcations  explain  the  morphology  of
he  disease:  spindle  shape  muscles  (Fig.  1),  with  a  globu-
ar  body,  preserved  tendon,  and  its  density  and  appearance:
ypodense  fatty  areas,  hyperintense  on  T1  and  T2  weighted




















AFigure 1. Typical muscle CT appearance in autoimmune thyrotox-
icosis (sagittal oblique reconstruction). Thin tendon (blue arrows)
and thickened muscle bodies (red arrows).
images,  hyperintense  inﬂammation  on  T2  images  persist-
ing  in  the  fat  suppression  or  Fat  Sat  images  (Fig.  2),  and
then  hypointense  ﬁbrosis  on  T1  and  particularly  T2  weighted
imaging.  While  unenhanced  CT  is  sufﬁcient  in  most  cases
to  make  a  diagnosis,  MRI  however  is  essential  to  diagnose
inﬂammation,  which  is  responsible  for  most  of  the  clinical
complications  of  the  disease  (diplopia,  reduced  visual  acu-
ity).  Concomitant  ophthalmological  signs  (retraction  of  the
upper  eyelid,  gritty  eyes)  which  are  generally  due  to  hyper-
thyroidism  may  guide  the  diagnosis  from  the  outset.  This
diagnosis  is  made  from  biological  conﬁrmation  of  dysthyroid
status.  It  should  be  remembered  that  exophthalmos  may  be
unilateral,  and  may  precede  the  ﬁnding  of  hyperthyroidism
(5  %  of  cases).  The  radiological  signs  of  this  disorder  there-
fore  need  to  be  understood  and  this  diagnostic  possibility
given  in  the  report.
KEY  POINT
The  investigation  MRI  protocol  for  dysimmune  orbital
disease  is  simple:  scout  view,  3  mm  axial  T2  weighted
sections  (to  assess  the  grade  of  the  exophthalmos  and
analyse  orbital  apex),  T2,  T1  and  T2  Fat  Sat  coronal
images,  positioning  these  from  the  most  anterior
part  of  the  globe  to  the  apex,  perpendicular  to  the
anteroposterior  axis  of  the  orbit. W
t
t
Figure 2. Bilateral exophthalmos due to dysthyroid orbital disease. 
sections (b). Muscle hyperintensity (red arrows) persisting with Fat Sat aigure 3. Lung cancer. Left exophthalmos. Metastatic lesion
hich has developed in the left medial rectus muscle.
What  if  the  muscle  lesion  is  not  autoimmune  thyrotox-
cosis?  Muscles  may  be  affected  by  myositis  (pain,  very
nﬂammed  appearance  of  one  or  more  muscles,  with  ten-
on  involvement),  a  secondary  tumor  (local  mass,  history  of
reast  or  lung  malignancy,  etc.)  (Fig.  3)  [5].
Orbital  wall  lesions  can  also  be  responsible  of  pro-
ressive  exophthalmos.  These  are  mostly  spheno-orbital
steomeningioma  with  a predominantly  bone  forming  com-
onent  (Fig.  4),  or  secondary  lesions  from  cancers  with  a
ropensity  to  spread  to  bone  (particularly  prostate).
The  space  occupying  effect  is  due  to  both  tissue  and
one.  Other  bone  lesions  such  as  ﬁbrous  dysplasia,  either
solated  or  as  part  of  the  McCune-Albright  syndrome,  osteo-
as  and  primary  lesions,  are  rarer  [6].
rbital inﬁltration
his  may  be  caused  by  a  malignant  blood  disorder  (lym-
homa  or  leukemia).  The  clinical  context  and  extension
re  very  helpful  in  making  the  diagnosis  (Fig.  5)  which  also
ncludes  inﬂammatory  diseases  such  as  sarcoidosis,  or  more
arely,  Wegener’s  disease.
n imaging investigation shows an orbital masshen  the  mass  is  isolated,  it  is  important  to  know  how  to  use
he  clinical  features  (past  history,  ophthalmological  signs),
he  image  appearance:  diffusion,  contrast  enhancement  (T1
Orbital MR with coronal T2 weighted sections (a) and T2 Fat Sat
nd reﬂecting acute inﬂammation.
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iigure 5. Four year old child with leukemia. Rapidly developin
nhancing with contrast (a), very cellular with B1000 hyperintensit
erfusion  weighted  image),  and  positional  maneuvers  in
rder  to  guide  the  diagnosis.
A  logical  approach  taking  account  of  the  incidence  of
he  lesions  is  needed.  A  tumor  which  is  clearly  delin-
ated,  hypointense  on  T1  weighted  imaging,  and  clearly
yperintense  on  T2  weighted  imaging,  dense  on  CT  with
eterogeneous  contrast  enhancement  rapidly  becoming
omogeneous  over  time,  (which  is  easy  to  see  if  enhanced
RI  views  are  taken  in  two  planes)  is  a  vascular  tumor  and
n  the  basis  of  incidence,  is  mostly  likely  to  be  a  cav-
rnous  angioma.  Despite  the  term  vascular  mass,  there  is
o  detectable  ﬂow  within  the  lesion  on  CDU  [7]  (Fig.  6).
The  main  differential  diagnosis  is  from  a  hemangioper-
cytoma,  which  is  far  more  aggressive,  and  often  has  a
eaker  hyperintensity  on  T2  weighted  imaging.  The  diag-
osis  is  often  made  from  progression  (rapid  growth,  unlike




igure 6. Examples of intra-orbital lesion, hypointense on T1 weighted
maging with an incomplete distinct hypointense halo (b). Cavernous hemht exophthalmos. Orbital site of the blood disease (red arrows)
 low ADC coefﬁcient (b).
hat to consider if it is not a cavernous
ngioma?
 lymphoma  or  malignant  blood  disorder  if  the  lesion  is
ery  cellular  (low  ADC).  Diffusion  weighted  imaging  should,
herefore,  form  part  of  all  protocols  used  to  investigate
rbital  masses  [9—11].
A  Schwannoma,  which  develops  on  the  branches  of  the
th  nerve,  or  oculomotor  nerves,  enhances  intensely,  and
rows  slowly,  and  when  it  becomes  bulkier  may  become
ystic  (Fig.  7)  [12].
A  primary  malignant  tumor,  particularly  sarcoma,  or
iposarcoma,  in  which  the  fat  component  is  often  very
inor.
A  cystic  lesion  suggests  a lymphangioma,  which  may  be
iagnosed  late,  and  also  a foreign  body  granuloma.  The
yst  content  is  protein-rich.  A  lesion  with  small  clearly
 imaging, enhancing progressively (a), hyperintense on T2 weighted
angiomas.
Tumor  pathology  of  the  orbit  937























mcontrast (b). Orbital Schwannoma.
delineated  cysts,  outside  of  a  clear  context  of  infection,  is  a
metastasis  until  proven  otherwise.  This  usually  develops  in
a  muscle  (the  second  commonest  site  after  the  choroid  for
orbital  secondary  lesions)  (Fig.  3).
Alternatively,  it  may  represent  an  inﬂammatory  lesion,
when  the  clinical  signs  are  suggestive  (orbital  pain,  chemo-
sis).  The  lesions  enhance  intensely  with  contrast  on  imaging
and  have  a  blurred  inﬂamed  appearance  in  the  adjacent
fat,  which  is  particularly  clearly  seen  on  T1  weighted  Fat
Sat  enhanced  and  T2  weighted  Fat  Sat  images  [13].  The  T2
weighted  hyperintensity  in  the  acute  phase  is  often  replaced
when  the  inﬂammation  becomes  chronic  by  a  hypointensity
representing  ﬁbrous  transformation.  The  preferred  sites  for
this  type  of  inﬂammation  are  the  lacrimal  gland,  periop-
tic  meninges  fat  and  oculomotor  muscles  (myositis).  Several
sites  of  disease  are  often  present  and  the  inﬂammation  may
even  be  bilateral  (Fig.  8).
Other  lesions  develop  in  contact  with  the  optic  nerve,
and  partially  or  completely  surrounds  it  (rail  line  appear-
ance  on  an  axial  view,  or  target  appearance  on  a  coronal
view,  formed  by  the  circumferential  lesions  centered  on  the
optic  nerve).  These  enhance  with  contrast  and  often  present
with  a  gradual  fall  in  visual  acuity,  which  patients  them-
selves  often  do  not  realize.  This  imaging  feature  is  usually
caused  by  an  optic  nerve  sheath  meningioma.  Computed
tomography  may  help  in  the  diagnosis  if  it  shows  calciﬁ-
cations  inside  the  lesion  (Fig.  9).  The  meningioma  has  the
typical  features  of  this  type  of  tumor,  with  intense  contrast
enhancement,  and  clear  demarcation.  It  may  be  circumfer-
ential  or  form  a  mass  and  cause  progressive  optic  atrophy.




Figure 8. Bilateral orbital inﬂammation (red arrows). Intense contrast 
on CDU (blue arrow, c).rbital  canal  to  the  endocranial  meninges  and  meninges  of
he  contralateral  optic  nerve.  Enhanced  MRI  with  thin  T1
at  Sat  axial  sections  is  the  best  monitoring  method  and
an  be  used  to  plan  when  surgery  may  be  needed  (Fig.  9)
14—16].
apid or sudden-onset exophthalmos
n  children,  this  may  be  due  to  a  malignant  tumor,  when
o  signs  of  inﬂammation  or  pain  are  present.  Urgent  imag-
ng  is  needed  as  it  may  reﬂect  a  rhabdomyosarcoma,  which
s  the  commonest  childhood  mesenchymal  tumor,  orbital
ites  of  which  are  usually  embryonic  tumors.  The  tumor
rows  extremely  quickly  and  on  imaging  appears  as  a  clearly
emarcated  mass,  which  is  dense  on  CT,  isointense  on  T1,
nd  hyperintense  T2  weighted  MR  images,  enhancing  with
ontrast,  and  often  containing  small  areas  of  hemorrhage.
hey  may  occur  in  isolation  or  in  conjunction  with  signs
eﬂecting  their  aggressive  nature,  including  destruction  of
he  orbital  wall  (30  to  40%  of  cases)  which  is  seen  clearly  on
T,  and  extension  to  the  sinuses  and  meninges.  They  require
rgent  management  with  biopsy  and  chemotherapy  (Fig.  10)
17].
Orbital  sites  of  malignant  blood  disorders  may  produce
n  identical  uni-  or  bilateral  clinical  picture.  The  lesion  is
ore  inﬁltrating,  and  diffusion  weighted  imaging  is  sugges-ive  (low  ADC  because  of  the  high  cellularity  of  the  masses).
 clinical  context  of  leukemia  helps  in  the  diagnosis  [18,19].
Rapid  or  sudden  exophthalmos  may  reﬂect  a  hematoma
t  any  age  (Fig.  11).
enhancement (a), ADC not reduced (b). Overall hypervacularization
938  F.  Héran  et  al.
Figure 9. Examples of intra-orbital optic nerve sheath meningiomas (asterisk) with atrophic optic nerve (red arrow, a), calciﬁed on CT
(red arrow, b), and extending to the apex of the orbit (blue arrow, c).
Figure 10. Rapidly progressive exophthalmos with right-sided wasting (a). T2 weighted MR (b) and T1 weighted enhanced Fat Sat (c):
lesion (red arrows) hyperintense on T2 weighted imaging and enhancing



























the  optic  nerve  (by  compression  or  stretching).  Surgeryigure 11. Left orbital hematoma with T2 weighted hypointensity
eﬂecting its acute nature (red arrow).
Apart  from  injury,  the  main  cause  to  consider  is  rupture
f  an  orbital  varix,  which  is  occasionally  difﬁcult  to  identify
n  the  acute  phase  [20].  A  varix  is  the  most  common  orbital
ascular  malformation  and  is  seen  on  imaging  views  taken
n  prone  position  (MRI,  CT)  or  hyperextension  (ultrasound
iews)  positions.  The  varix  increases  in  volume  with  these
i
m
o with contrast. Transferred to a specialist center and biopsied on
ositional  maneuvers  on  all  imaging  methods.  Additional
eatures  supporting  the  diagnosis  include  a  description  of
xophthalmos  varying  with  position  given  by  the  patient  (the
atient’s  eye  ‘‘comes’’  out  when  he/she  leans  forward),
hleboliths  on  CT,  bidirectional  ﬂow  on  CDU,  and  a  lesion
ith  serpiginous  morphology  (Fig.  12).
Bleeding  within  a  cystic  lymphangioma  should  be  consid-
red  in  children.  Cystic  lymphangioma,  a hemodynamically
ndependent  hamartoma,  is  one  of  the  angiodysplasias  and
onsists  of  branching  abnormal  lymphatic  vessels  present
rom  birth,  accounting  for  1%  of  orbital  tumors  and  12%  of
ascular  tumors  [21]. It  is  diagnosed  early,  usually  before
he  age  of  10  years  old.  Complications  develop  shortly
fter  the  diagnosis,  at  around  the  age  of  13.  The  tumor
as  pleomorphic  clinical  features,  with  both  superﬁcial
nd  deep  lesions  causing,  occasionally  severe,  progres-
ive  exophthalmos,  which  may  develop  suddenly.  This  is
ue  to  reactive  lymphoid  hyperplasia,  as  a result  of  an
NT  infection,  or  hemorrhage  within  the  lesion,  and  may
equire  urgent  surgery  because  of  the  risk  of  damage  tonvolves  draining  the  largest  hemorrhagic  cysts  and  less  com-
only,  excision.  Some  believe  that  surgery  increases  the  risk
f  recurrent  hemorrhage.  The  heterogeneous  appearances









eFigure 12. Left orbital varix (red arrow). T1 weighted MR with e
prone/hyperextended (c and d) position. The lesion increases in vo
of  the  lesion  are  explained  by  its  type  and  progression.
Imaging  shows  more  or  less  extensive  orbital  inﬁltration
by  cystic  lesions  of  variable  volume  and  number,  and/or
hemorrhagic  lesions  with  ﬂuid  levels  in  the  acute  phase
(Fig.  13).  The  lesion  may  be  localized  to  the  orbit  or
may  extend  to  the  deep  facial  bones,  neck  or  pharynx
and  therefore  requires  a  staging  assessment,  which  is  eas-
ier  with  MRI  than  CT.  The  most  ‘‘productive’’  view  is  T2
weighted  Fat  Sat  either  3D  or  axial  and  coronal  plane
imaging  covering  all  of  the  regions  potentially  involved
[22—24].
Far  more  rarely,  an  orbital  hematoma  is  caused  by  hem-





Figure 13. T2 weighted axial Fat Sat orbital MR (a) and cervico-facial
blood ﬂuid level (red arrow). Multiple other sites (yellow arrows).ed Fat Sat and CDU with the patient in decubitus (a and b) and in
 after changing position.
f  another  intra-orbital  vascular  malformation  (AVM,  oph-
halmic  artery  aneurysm).
Sudden-onset  exophthalmos  may  also  reﬂect  intra-orbital
rift  of  a  frontal  or  ethmoid  mucocele,  particularly  after
 patient  has  blown  his/her  nose,  causing  a  fracture  of
he  sinus  wall.  This  is  usually  easy  to  diagnose  on  imaging
Fig.  14)  [26].
What  imaging  should  be  carried  out  for  sudden-onset
xophthalmos?  The  investigation  to  perform  in  this  situation
s  CT.  In  rapidly  progressing  exophthalmos  in  a  child,  MRI
hould  be  performed  if  possible  as  this  provides  evidence  of
habdomyosarcoma  if  present  and  provides  a  better  staging
ssessment  than  CT.
 coronal MR (b). Left orbital cystic lymphangioma with liquid-fresh
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Figure 14. CT (a) and T2 weighted MR (b). Ethmoid mucocele presenting with sudden-onset exophthalmos, hyperdense protein content,
hypointense on T2 weighted imaging (red arrow).
Lacrimal gland disease
The  clinical  presentation  of  lacrimal  gland  hypertrophy  is
highly  suggestive  with  a  ‘‘comma’’  appearance  at  the  lateral
end  of  the  eyebrow  (Fig.  15)  [27].
Lacrimal  gland  lesions  can  be  divided  into  two  histolog-
ical  categories,  each  including  both  benign  and  malignant
lesions.  The  epithelial  lesions  (45  to  50%)  include  dacry-
ops,  and  pleomorphic  adenomas,  and  the  non-epithelial
lesions  (50  to  55%)  include  dacryoadenitis,  non-Hodgkin’s
lymphoma,  and  benign  lymphoid  hyperplasia.  Two  diagnostic
approaches  can  therefore  be  considered  to  look  for  tumor
and  inﬂammation.  Imaging  such  as  ultrasound  conﬁrms  the
site  of  the  lesion  although  deﬁnition  of  the  lesion  relies
particularly  on  MRI  and  ultrasound.  We  only  consider  the
common  lesions  here.
A  pleomorphic  adenoma  or  mixed  tumor  has  dual
epithelial  and  myxoid  components.  When  typical,  it  is  char-
acteristic  on  MRI  with  an  obvious  hyperintensity  on  T2
weighted  imaging,  and  pronounced  heterogeneous  enhance-
ment  (unless  it  is  small),  with  a  type  I  dynamic  curve,  which
is  hyperintense  on  a  B1000  diffusion  weighted  image  with  a
high  ADC  (Fig.  16).
Figure 15. Characteristic left lacrimal gland hypertrophy (red
arrow).
Dacryops  is  a  dilatation  of  the  intraglandular  duct  struc-
tures,  and  presents  as  a  uni-  or  multicystic  structure
[28].
Non-hematological  malignant  tumors  (adenocarcinoma,
cystic  adenoid  carcinoma)  are  often  heterogeneous,  and
poorly  demarcated,  hypointense  on  T2  weighted  imag-
ing  with  a low  ADC  and  a  type  II  or  III  enhancement
curve.  The  staging  assessment  is  by  MRI.  CT  is  performed
in  addition  in  aggressive  disease  involving  the  orbital
wall.
Inﬂammatory  lesions  may  be  idiopathic  or  occur  as  a
complication  of  sarcoidosis,  or  Wegener’s  disease.  These  are
uni-  or  bilateral,  and  either  isolated  or  associated  with  more
diffuse  orbital  involvement.  They  are  often  hypointense  on
T2  weighted  imaging  (ﬁbrous  component),  with  no  fall  in
the  ADC  (unlike  lymphoma)  (Fig.  8).  In  superﬁcial  masses,
CDU  clearly  distinguishes  between  blood  malignant  disorders
(hypoechogenic  nodules  separated  by  hypervascularized
lines)  (Fig.  17)  and  inﬂammation  (hypervascularized  anar-
chic  mass)  (Fig.  12)  [29].
Periorbital lesions
The  diagnostic  approach  to  a  periorbital  region  mass  is  based
on  the  clinical  appearances  and  age  of  the  patient.  The
predominant  causes  of  etiologies  are  vascular  lesions,  infec-
tions,  and  skin  tumors.
Figure 16. T2 weighted orbital MR. Right pleomorphic lacrimal
gland adenoma (red arrow).
Tumor  pathology  of  the  orbit  941
Figure 17. T1 weighted enhanced Fat Sat orbital (a) and diffusion ADC (b) MR, and CDU (c). Left lacrimal gland lymphoma (red arrow).
Figure 18. T2 weighted orbital MR (a) and right palpebral CDU (b). Ju
A  purple  colored,  renitent  palpebral  swelling  in  an  infant
is  highly  suggestive  of  a  juvenile  papillary  angioma.  CDU
appearances  are  characteristic  (fetal  hypervascularization)
(Fig.  18).  This  resolves  spontaneously  in  95%  of  cases,
between  the  age  of  1  and  6  years  old,  and  may  occur  in  iso-
lation  or  as  part  of  a  malformation  syndrome  (Sturge  Weber,
PHACE,  Bonnet-Dechaume-Blanc)  [30,31].
An  external  swelling  of  the  canthus  in  a  child  is  usu-
ally  a  dermoid  cyst  (a  cyst  at  the  end  of  the  eyebrow).
Unenhanced  CT  is  sufﬁcient  to  investigate  for  intra-orbital
extension  or  conﬁrm  the  type  of  lesion  before  planning
surgery  (Fig.  19).
If infection  is  suspected  in  a  child  or  adult,  orbital
CT  is  performed  with  enhancement  from  the  outset  with
the  purpose  of  distinguishing  preseptal  infection  (gener-
ally  originating  from  the  lacrimal  gland:  dacryocystitis,
only  requiring  antibiotic  therapy)  or  with  retroseptal
extension  (generally  of  sinus  origin  or  post-traumatic,






























dvenile angioma (red arrow).
nd  requiring  intensive  management  with  hospitalization
nd  intravenous  therapy).  It  is  also  useful  to  iden-
ify  the  cause  (sinusitis,  dacryocystitis,  foreign  body,
tc.).
Retroseptal  extension  behind  the  line  passing  through
he  middle  of  the  globe  may  occur  into  fat  (dense,  with
erioptic  contrast  enhancement),  and  oculomotor  muscles
increase  in  volume,  intense  contrast  enhancement).  This
ay  be  complicated  by  an  intra-orbital  abscess  spreading
long  the  walls  (a  mass  with  a hypodense  center  with  periph-
ral  contrast  enhancement)  (Fig.  20).
Clinical  features  may  be  suggestive  of  a  malignant
umor  of  skin  origin  (for  example  a  basal  cell  or  squa-
ous  cells  carcinoma),  assessment  of  which  is  done  with
RI.
nophthalmos and intra-orbital lesions
nophthalmos  is  due  to  enlargement  of  the  orbit  (post-
raumatic,  postoperative  or  malformation),  or  to  reduction
n  the  volume  of  the  orbital  contents  (for  example  after
urgery  or  radiotherapy).  Paradoxically,  some  intra  orbital
asses  also  present  with  enophthalmos.  The  leading  cause
o  consider  with  a  mass  which  is  ﬁbrous  in  appearance,
ypointense  on  T2  weighted  imaging,  and  enhances  with
ontrast  is  a metastasis  of  a  scirrous  cancer,  above  all  from
he  breast,  and  occasionally  from  the  stomach  (Fig.  21).
his  secondary  site  may  be  the  presenting  feature  and  these
otential  causes  should  be  suggested  in  the  report  (suggest
hat  markers  and  mammography  be  performed  if  breast  can-
er  is  not  known)  [32—34].  These  ﬁbrous  masses  may  also
epresent  a  chronic  inﬂammatory  lesion.  This  is  an  end  point
f  known  inﬂammation,  the  diagnosis  of  which  raises  no
ifﬁculties.
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Figure 20. Enhanced orbital CTs in two patients. Preseptal orbital cellulitis (a) with dacryocystitis (red arrow) and retroseptal cellulitis
(b) with contiguous subperiostial abscess (red arrow).














• Progressive  exophthalmia:  dysimmune  orbital
disease.
• Intra-orbital  mass:  cavernous  hemangioma.
• Cystic  lesion:  lymphangioma,  schwannoma,
metastasis  (microcysts).
• Infection:  distinguish  between  pre-  and  retroseptal
site,  an  enhanced  CT  is  sufﬁcient.
• Variable  exophthalmos:  varix?  Consider  a  leaning
forward  view.
• Children  and  rapid  exophthalmos:
rhabdomyosarcoma,  perform  urgent  imaging.
• Sudden-onset  exophthalmos:  hematoma  (varix?),
mucocele.
• Enophthalmos  and  mass:  metastasis  from  breast
cancer,  chronic  inﬂammation,  varix.
C
Aeft enophthalmos.
Finally,  it  should  be  noted  that  after  long  term  progres-
ion  with  ﬂares  of  exophthalmos  and  hemorrhagic  changes,
rbital  varices  may  lead  to  intra-orbital  lipolysis  and  pro-
ressive  enophthalmos  [35].
KEY  POINT
Metastasis  of  a  breast  cancer  or  inﬂammation  should
be  considered  in  enophthalmos  and  if  the  patient
has  a  clinical  history  of  exophthalmos  followed  by
enophthalmos,  the  imaging  assessment  should  be
combined  with  a  leaning  forward  view,  which  will
conﬁrm  the  diagnosis  of  a  varix.
onclusion
he  clinical  features  (patient  age  and  presentation)  are
ssential  factors  in  the  assessment  of  an  orbital  tumor.  MRI
s  the  preferred  investigation  except  in  urgent  situations  or
n  exophthalmos  suggestive  of  autoimmune  thyrotoxicosis.
he  investigation  will  often  need  to  be  extended  beyond  the






 69  year  old  patient  presents  with  a  periorbital  swelling
or  a  month  which  has  gradually  been  worsening.  She
as  slight  local  pain  and  a  past  history  of  Hodgkin’s
isease  eight  years  previously,  currently  in  remission
Fig.  22).




[Figure 22. CDU (a), T2 weighted (b), T1 weighted Gd Fat Sat (c)
Questions
1.  What  is  the  site  of  the  lesion?
2.  How  does  this  lesion  behave  on  CDU?
3.  What  is  the  lesion  image  signal?  What  image  sequence  is
particularly  useful  to  characterize  it?
4.  What  is  your  diagnosis  and  what  is  the  management?
Answers
1.  The  lesion  has  developed  in  the  left  lacrimal  gland  and
extends  to  the  adjacent  soft  tissues.  Extension  of  con-
trast  enhancement  is  seen  on  the  T1  weighted  image  to
the  internal  region  of  the  canthus.
2.  It  is  hypervascularized,  anarchic,  and  overall  slightly
hyperechogenic.
3.  The  lesion  is  hypointense  on  T2  weighted  imaging,  and
intensely  enhances  with  contrast.  On  diffusion  weighted
imaging,  it  is  paucicellular  and  has  a  relatively  high
ADC.  This  latter  view  provides  reassuring  evidence  in  this
patient  with  a  past  history  of  a  malignant  blood  disor-
der.  The  high  ADC  argues  against  the  diagnosis  of  a  site
of  hematological  disease,  which  would  have  a  very  low
ADC.
4.  The  most  likely  diagnosis  is  inﬂammation  of  the  lacrimal
gland  (or  dacryoadenitis).  A  general  assessment  into  the
cause  is  needed  (investigating  for  sarcoidosis,  Wegener’s
disease,  etc.).  Treatment  is  with  corticosteroid  therapy.
Clinical  and  MRI  follow  up  are  required  and  if  the  lesion
persists  or  increases  in  volume,  a  biopsy  may  be  offered.Disclosure of interest
The  authors  declare  that  they  have  no  conﬂicts  of  interest
concerning  this  article.
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